Mylan Earnings: Problems Beyond Bad Timing - Bloomberg
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva, Glenmark accuse U.S. government of improperly expanding price-fixing case | Fierce Pharma
Teva Soars as Generic Drugmaker Tops Earnings Estimates - TheStreet
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Opioid epidemic in the United States - Wikipedia
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission - The Lancet
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Cancer drug shortages could be avoided amid Covid-19 pandemic
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx | Fierce Pharma
Allergan, Teva and others start 2018 with price hikes: analyst | Fierce Pharma
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
King of Generics Pushes Into Biotech Drugs - WSJ
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much | Fierce Pharma
Teva, amid massive restructuring, closes in on $3B cost-cutting goal | Fierce Pharma
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
Teva, after locking up new Ajovy patents, sues Eli Lilly again in heated migraine drug fight | Fierce Pharma
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ELYBYTG4QZMUJPXRYDKAVNSTAI.jpg "New branded drugs helping Teva Pharm move closer to growth | Reuters")
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report | Fierce Pharma
